• Evonik’s biotechnology platform covers the entire bandwidth from cutting-edge research to production network.
• The first Friedrich Bergius Lecture award in Greater China region was presented to Prof. Tianwei Tan
For the eighth time since 2004, Evonik held the “Evonik Meets Science China” symposium in Beijing on March 22 to 23, with the theme on “Industrial Biotechnology”. More than 100 experts and professors specialized in industrial biotechnology from Evonik, leading biotechnology institutes and universities joined the event.
Mr. Shousheng Li, Executive Vice Chairman of China Petroleum and Chemical Industry Federation (CPCIF), also attended and delivered a keynote speech. “In line with the megatrend of globalization of technologies, this event sets up a good example to exchange and transfer of industry knowledge. It is important for the Chinese enterprises to learn from advanced concepts and work closely together to promote the further upgrading of industrial structure.”
“Based on the motto ‘Open Innovation’, Evonik works with the academia in China to ensure the top research findings on sustainable aspects are rapidly transferred to the industry,” said Dr. Klaus Engel, Chairman of Evonik Industries at the event. “Today China owns numerous groups of world-class institutes and experts in chemistry. Evonik therefore attaches great importance to keep the dialogues and cooperation with Chinese scientists.”
Biotechnology is a firm part of Evonik’s growth strategy. Today, products manufactured with biotech processes already generate several hundred million euros of sales for Evonik around the globe. Evonik’s biotechnology platform covers the entire bandwidth – from researching new stems and enzymes all the way to a production network worldwide.
In China, Evonik has established the Creavis Bio Lab in Shanghai in 2013 to develop biotechnological processes with yeasts that contribute to the future chemical business. By combining this unique biotechnology platform with equally comprehensive chemical know-how, Evonik creates value and generates future growth.
“The EMSC 2015 provides valuable platform to leverage the research of outstanding Chinese scientists and Evonik’s leading technologies,” said Dr. Ulrich Kuesthart, Chief Innovation Officer of Evonik Industries, “Through active cooperation with academic networks, our own competencies in biotechnology are amplified.”
During the two-day symposium, Evonik also presented its first Friedrich Bergius Lecture award in the Greater China region to Professor Tianwei Tan, President of Beijing University of Chemical Technology. In his speech, Professor Tan as leading expert gave an overview of current research focuses of industrial biotechnology in China and future trends to all the participants. Friedrich Bergius Lecture was named after the German Chemist who received the Nobel Prize for Chemistry in 1931 jointly with Carl Bosch. Dr. Bergius worked for one of the predecessor companies of Evonik. His research continues to influence some of the chemicals produced at Evonik to this day.
Evonik, the creative industrial group from Germany, is one of the world leaders
in specialty chemicals. Profitable growth and a sustained increase in the value of the company form the heart of Evonik’s corporate strategy. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative prowess and integrated technology platforms. Evonik is active in over 100 countries around the world. In fiscal 2014 more than 33,000 employees generated sales of around €12.9 billion and an operating profit (adjusted EBITDA) of about €1.9 billion.
Evonik Industries has been producing specialty chemical products in the Greater China region (Mainland China, Hong Kong and Taiwan) since the late 1970’s; with wide-ranging trading relations already in place prior to this in the region. Evonik regards Greater China as one of the driving forces of the global economy and we consequently endeavour to grow our business in the region. The company now has around 3,000 employees in the Greater China region, the regional sales reached over €1.1 billion in 2014.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.